Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BLUCVE:IVI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBLUBELLUS Health$14.74$14.62$6.38▼$14.76$1.87B0.193.08 million shs3.45 million shsIVIIvrnetC$0.01-50.0%C$0.01C$0.01▼C$0.02C$497K0.22317,251 shs310,000 shs13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBLUBELLUS Health0.00%0.00%0.00%0.00%0.00%IVIIvrnet0.00%0.00%0.00%0.00%0.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBLUBELLUS HealthN/AN/AN/AN/AN/AN/AN/AN/AIVIIvrnetN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBLUBELLUS Health 0.00N/AN/AN/AIVIIvrnet 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBLUBELLUS Health$15K124,613.93N/AN/A$3.09 per share4.77IVIIvrnetC$2.83M0.18C$0.00 per share22.50C($0.05) per share-0.10Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBLUBELLUS Health-$76.08M-$0.72N/AN/AN/A-578,586.63%-24.27%-23.14%N/AIVIIvrnetN/AN/AN/A∞N/A-9.82%N/A24.67%N/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBLUBELLUS HealthN/AN/AN/AN/AN/AIVIIvrnetN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBLUBELLUS HealthN/A33.4233.42IVIIvrnet692.590.120.14Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBLUBELLUS Health90.37%IVIIvrnetN/AInsider OwnershipCompanyInsider OwnershipBLUBELLUS Health24.17%IVIIvrnet24.29%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBLUBELLUS Health74126.81 million96.16 millionNot OptionableIVIIvrnetN/A99.31 millionN/ANot OptionableIVI, JEDT, BLU, and HET HeadlinesRecent News About These CompaniesIvrnet Inc. Terminates Definitive Agreement With Flexity Systems Ltd. for Proposed Reverse Takover TransactionJune 27, 2023 | finance.yahoo.comIvrnet Inc.: Ivrnet Announces Financial Results for Fiscal Year Ended 2022April 26, 2023 | finanznachrichten.deIvrnet Announces Financial Results for Fiscal Year Ended 2022April 26, 2023 | finance.yahoo.comIvrnet Inc. Announces Extension to DebentureApril 17, 2023 | finance.yahoo.comFace and Voice Biometrics Market Size, Share and Forecast 2030 | 3M Cogent (USA), NEC Corporation of America (USA), AcSys Biometrics Corp. (Canada)April 8, 2023 | marketwatch.comIvrnet Inc. Announces Extension to Term Loan and Credit Facility and Amendment to Previously Issued Convertible DebenturesMarch 15, 2023 | finance.yahoo.comIvrnet Inc. (IVI.V)February 17, 2023 | finance.yahoo.comIvrnet Inc. Announces Amendment to Term Loan and Credit FacilityDecember 31, 2022 | finance.yahoo.comIvrnet Q2 EBITDA of $157,287August 31, 2022 | seekingalpha.comIvrnet Provides Update on Trading HaltJune 30, 2022 | apnews.comTwitter agrees to pay $150M for breaking privacy promisesMay 27, 2022 | yahoo.comThe Worst Thing You Can Do At Work After Another Mass Shooting Is NothingMay 27, 2022 | yahoo.comTwitter stock jumps on news that Elon Musk still wants to buy it … maybeMay 27, 2022 | yahoo.comIvrnet Inc.: Ivrnet Announces Financial Results for Fiscal Year Ended 2021 and Provides Update on Trading HaltApril 28, 2022 | finanznachrichten.deIvrnet Announces Financial Results for Fiscal Year Ended 2021 and Provides Update on Trading HaltApril 28, 2022 | morningstar.comIvrnet Inc. Selects eStruxture Data Centers as Partner to Design a ...August 24, 2021 | pr-inside.comIvrnet Inc. Selects eStruxture Data Centers as Partner to Design a Cloud and Connectivity Strategy to Boost Business Agility and Speed Up InnovationAugust 24, 2021 | apnews.comIvrnet Announces Filing of Interim Financial StatementsAugust 21, 2021 | markets.businessinsider.comIVRnet Inc.August 6, 2021 | barrons.comTop HeadlinesView All Headlines3 High-Paying Dividend Stocks That Still Have Safe PayoutsBy Chris Markoch | May 27, 2025View 3 High-Paying Dividend Stocks That Still Have Safe PayoutsDividend Investors Looking for an Edge? 3 Stocks Insiders BoughtBy Thomas Hughes | May 29, 2025View Dividend Investors Looking for an Edge? 3 Stocks Insiders BoughtThese 3 Dividend Stocks Combine Strong Yields With UpsideBy Chris Markoch | June 20, 2025View These 3 Dividend Stocks Combine Strong Yields With Upside3 Top Dividend Stocks Analysts Are Bullish on Right NowBy Chris Markoch | June 6, 2025View 3 Top Dividend Stocks Analysts Are Bullish on Right NowMicrosoft's Outlook Brightens as Analysts Boost Bullish RatingsBy Chris Markoch | May 27, 2025View Microsoft's Outlook Brightens as Analysts Boost Bullish RatingsIVI, JEDT, BLU, and HET Company DescriptionsBELLUS Health NASDAQ:BLUBELLUS Health Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. BELLUS Health Inc. was incorporated in 1993 and is based in Laval, Canada. As of June 28, 2023, BELLUS Health Inc. operates as a subsidiary of GSK plc.Ivrnet CVE:IVIC$0.0050 -0.01 (-50.00%) As of 10/27/2023Ivrnet Inc., a software and communications company, develops, hosts, sells, and supports value added business automation software solutions in Canada and the United States. Its applications facilitate automated interaction through personalized communication between people; mass communication for disseminating information to thousands of people concurrently; and personalized communication between people and automated systems. The company also provides IT services and software development services, as well as sells equipment; communication services, such as telephone, fax, toll, audio conference, and invoicing services; texting and text advertising services; business services comprising website, server, community management, and registration system hosting; and payment card industry services. In addition, it engages in the provision of software-related services, including training, installation, consulting, and maintenance. Ivrnet Inc. was incorporated in 1999 and is based in Calgary, Canada More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Microsoft Stock Holds Steady as AI Drives Workforce Shift Top International ETFs With Dividends and Market-Beating Returns D-Wave Goes International With South Korea Partnership BigBear.ai Poised to Benefit as Palantir Dominates AI Defense Kroger Stock Confirms Buy Signal as Uptrend Gains Strength Darden Stock Set to Sizzle After Blowout Q4 and $1B Buyback Alphabet’s Comeback: The Hidden Engines Powering Google New All-Time Highs Coming for Broadcom? Wall Street Says Yes Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
